opportunities. The paper also provides new evidence on induced pharmaceutical innovation. In both cases we use the change in the … demographic structure of the market (measured by age structure and obesity prevalence) to test the induced innovation hypothesis … pharmaceutical innovation responds to aging- and obesity-induced changes in potential market size …

an induced innovation externality. This alternative mechanism, by contrast, causes people to devote an inefficiently high … level of self-protection. As an empirical example of this externality, we analyze the innovation induced by the obesity … epidemic. Obesity is associated with an increase in the incidence of many diseases. The induced innovation hypothesis is that …

from pharmaceutical innovation. Extending previous studies of the welfare benefits from innovation (Trajtenberg, 1990 …

solutions are applied to the case of Computed Tomography (CT) Scanners, a pathbreaking innovation in medical technology. The …

applied to the case of Computed Tomography (CT) Scanners, a revolutionary innovation in medical technology. The econometric … from innovation is used primarily to compute a social rate of return to R&D, to explore the interrelation between … innovation and diffusion, and to trace the time profile of benefits and costs, the latter suggesting the possible occurance of …

segmentation) shaped the underlying incen- tives for innovation in the PC industry during the mid to late 1980s …